Rock Springs Capital Management LP Q4 2017 Filing
Filed February 14, 2018
Portfolio Value
$2.2T
Holdings
144
Report Date
Q4 2017
Filing Type
13F-HR
All Holdings (144 positions)
| Stock | Value |
|---|---|
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $5.9M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $5.8M |
DVADAVITA INC | $5.8M |
CHRSCOHERUS BIOSCIENCES INC | $5.5M |
EX9EXELIXIS INC | $5.3M |
MRUSMERUS N V | $5.3M |
—RA PHARMACEUTICALS INC | $5.1M |
—MEDICINES CO | $4.6M |
HRTXHERON THERAPEUTICS INC | $4.5M |
CRVSCORVUS PHARMACEUTICALS INC | $4.4M |
MGNXMACROGENICS INC | $4.3M |
GTHXEURG1 THERAPEUTICS INC | $4.3M |
CBAYUSDCYMABAY THERAPEUTICS INC | $4.1M |
BCRXBIOCRYST PHARMACEUTICALS | $4.0M |
—PROTEOSTASIS THERAPEUTICS IN | $3.9M |
—EGALET CORP | $3.8M |
—NABRIVA THERAPEUTICS PLC | $3.7M |
—MYOVANT SCIENCES LTD | $3.7M |
IRWDIRONWOOD PHARMACEUTICALS INC | $3.4M |
MRTXEURMIRATI THERAPEUTICS INC | $3.3M |
DVAXDYNAVAX TECHNOLOGIES CORP | $3.3M |
—MEDICINES CO | $3.2M |
—ADURO BIOTECH INC | $3.1M |
BMYBRISTOL MYERS SQUIBB CO | $3.1M |
—ALLERGAN PLC | $2.9M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $2.8M |
ITCIEURINTRA CELLULAR THERAPIES INC | $2.7M |
NVAXNOVAVAX INC | $2.5M |
MCRB1EURSERES THERAPEUTICS INC | $2.2M |
RYTMRHYTHM PHARMACEUTICALS INC | $2.1M |
CGENCOMPUGEN LTD | $2.1M |
—CIDARA THERAPEUTICS INC | $2.0M |
—CARDIOME PHARMA CORP | $1.9M |
—DBV TECHNOLOGIES S A | $1.8M |
SCYXEURSCYNEXIS INC | $1.8M |
NVLSEURALPINE IMMUNE SCIENCES INC | $1.7M |
—ATYR PHARMA INC | $1.7M |
—THERAVANCE BIOPHARMA INC | $1.6M |
—RADIUS HEALTH INC | $1.4M |
—WRIGHT MED GROUP INC | $1.0M |
—CHIASMA INC | $893K |
INFIQINFINITY PHARMACEUTICALS INC | $548K |
—OREXIGEN THERAPEUTICS INC | $213K |
DAREDARE BIOSCIENCE INC | $135K |
PreviousPage 2 of 2